I don't think current price fully reflected the significance of the announcement, the independent committees do not make this kind of recommendation lightly, it's not only made FDA approval almost certain, more importantly imho it indicated the superiority of Technegas to alternatives and rapid market expansion after the approval. Have a look at the CEO's take about the announcement:
https://www.finnewsnetwork.com.au/archives/finance_news_network286908.html
Ann: Technegas USA Trial Successfully Meets Primary Endpoint, page-14
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
93.0¢ |
Change
0.020(2.20%) |
Mkt cap ! $103.3M | |||
| Open | High | Low | Value | Volume |
| 92.5¢ | 95.0¢ | 90.5¢ | $82.50K | 90.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 4766 | 1 |
View Market Depth
| Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |